[HTML][HTML] Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials
M Miszczyk, T Wu, K Kuna, M Stankiewicz… - Clinical and …, 2024 - Elsevier
Background Concurrent chemoradiotherapy (CRT) is the standard treatment for locally
advanced cervical cancer. We investigated how additional bone marrow sparing (BMS) …
advanced cervical cancer. We investigated how additional bone marrow sparing (BMS) …
Recent Advances in the Management of Anal Cancer
L Upadhyay, M Hartzell, AR Parikh, MR Strickland… - Healthcare, 2023 - mdpi.com
The incidence and mortality of squamous cell carcinoma of the anus (SCCA) is on the rise,
which highlights the unmet need for advances in treatment options. The landscape of …
which highlights the unmet need for advances in treatment options. The landscape of …
A machine-learning-based bibliometric analysis of the scientific literature on anal cancer
P Franco, E Segelov, A Johnsson, R Riechelmann… - Cancers, 2022 - mdpi.com
Simple Summary Squamous-cell carcinoma of the anus, being a rare cancer, requires
national and international collaborations, networking, organizational proficiency and …
national and international collaborations, networking, organizational proficiency and …
Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer
MP Nilsson, A Johnsson, J Scherman - Radiation Oncology, 2021 - Springer
Background Treatment-related white blood cell (WBC) toxicity has been associated with an
inferior prognosis in different malignancies, including anal cancer. The aim of the present …
inferior prognosis in different malignancies, including anal cancer. The aim of the present …
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10–2 trial)
KN Murofushi, S Itasaka, M Shimokawa… - Journal of Radiation …, 2023 - academic.oup.com
This study assessed the efficacy of chemoradiotherapy for squamous cell carcinoma of the
anal canal (SCCAC). Patients with T1–4N0-3M0 SCCAC received chemoradiotherapy with …
anal canal (SCCAC). Patients with T1–4N0-3M0 SCCAC received chemoradiotherapy with …
Feasibility of identifying proliferative active bone marrow with fat fraction MRI and multi-energy CT
M Lawless, K Byrnes, BP Bednarz… - Physics in Medicine …, 2024 - iopscience.iop.org
Objective: Active bone marrow (ABM) can serve as both an organ at risk and a target in
external beam radiotherapy. 18F-fluorothymidine (FLT) PET is the current gold standard for …
external beam radiotherapy. 18F-fluorothymidine (FLT) PET is the current gold standard for …
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono …
ML Bonù, S La Mattina, N Singh, C Toraci… - Frontiers in …, 2022 - frontiersin.org
Introduction Radiochemotherapy (RCHT) for the treatment of anal squamous cell carcinoma
(ASCC) has evolved dramatically, also thanks to intensity-modulated RT (IMRT) and 3D …
(ASCC) has evolved dramatically, also thanks to intensity-modulated RT (IMRT) and 3D …
A pattern of care report on the management of patients with squamous cell carcinoma of the anus—A study by the Italian association of radiotherapy and clinical …
P Franco, G Chiloiro, G Montesi, S Montrone, A Arcelli… - Medicina, 2021 - mdpi.com
Background and objectives: The diagnosis and therapy of squamous cell carcinoma of the
anus may vary significantly in daily clinical practice, even if international guidelines are …
anus may vary significantly in daily clinical practice, even if international guidelines are …
[PDF][PDF] Laurie Spehner, Hopital Jean Minjoz, France
A Fiorentino, OG Regionale, F Miulli, ID Gilbert… - 2022 - academia.edu
Anal squamous cell carcinoma (ASCC) is a rare disease with an increasing incidence. HPV
infection is associated with up to 93% of cases (1–4). Immuno-evasion plays a significant …
infection is associated with up to 93% of cases (1–4). Immuno-evasion plays a significant …
[PDF][PDF] Assessment of Healthy Tissue Metabolism to Predict Outcomes in Oncologic [18F] FDG
AA Malaih - 2022 - kclpure.kcl.ac.uk
Abstract Background: The use of 2-[18F] Fluoro-2-deoxy-d-glucose ([18F] FDG) in positron
emission tomography/computed tomography (PET/CT) imaging is not specific to oncologic …
emission tomography/computed tomography (PET/CT) imaging is not specific to oncologic …